OPKO Health, Inc. (OPK)
| Market Cap | 2.55B |
| Revenue (ttm) | 1.77B |
| Net Income (ttm) | 120.80M |
| Shares Out | 640.85M |
| EPS (ttm) | 0.19 |
| PE Ratio | 19.87 |
| Forward PE | 16.08 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 21 |
| Last Price | $3.76 |
| Previous Close | $3.70 |
| Change ($) | 0.06 |
| Change (%) | 1.49% |
| Day's Open | 3.76 |
| Day's Range | 3.69 - 3.78 |
| Day's Volume | 1,849,434 |
| 52-Week Range | 2.38 - 6.47 |
OPKO Health (OPK) expects to improve its business efficacy and focus on oral solid dose products post the sale of its Ireland facility.
OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4 chronic kidney disease with Ni...
MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of Nicoya...
OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc (NASDAQ: HZNP) for $65 million. The facility ho...
MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Wate...
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?
MIAMI, May 27, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 1-4, 2021. Ma...
MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Ca...
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
Looking for penny stocks to buy during a market correction? Check these 4 out for your watchlist The post Best Penny Stocks to Buy During a Market Correction?
MIAMI, May 07, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has entered into exchange agreements with certain noteholders of the Company's 4.50% Convertible Senior Notes due 2025 (“Notes”). ...
OPKO Health's (OPK) first-quarter results benefit from strength in diagnostics.
OPKO Health (OPK) delivered earnings and revenue surprises of 0.00% and 8.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 155.56% over the past year to $0.05, which were in line w...
Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today
OPKO Health's (OPK) BioReference expands its major league sports relationships with the announcement of COVID-19 testing agreement with MLB.
OPKO Health's (OPK) BioReference expands COVID-19 testing in schools to create a safer learning environment for students, teachers, staff and their families.
ELMWOOD PARK, N.J., March 26, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the expansion of its COVID-19 school testing program to support...
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?
These seven penny stocks are most likely to push through the $5 mark having built a significant head of steam in the past year. The post 7 Penny Stocks Close To Busting Through the $5 Mark appeared firs...
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.
NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorizatio...
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locatio...
OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.
Opko Health Inc (NASDAQ: OPK) reported Q4 results that came in above expectations with EPS of $0.05 beating the estimate of $0.04 and sales of $494.6 million higher than the consensus of $443.1 million....
Hint: Investors are more focused on concerns about the future than successes of the recent past.
OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 266.67% over the past year to $0.05, which beat the estim...
OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.
MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guidan...
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...
Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity.
OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.
OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
ELMWOOD PARK, N.J., Jan. 13, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platform pr...
Calls on Analysts and Stockholders Attending J.P. Morgan's Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q'20 Guidance Calls on Analysts and Stockho...
OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.
It's the perfect time for a wealthy CEO to ride off into the sunset.
MIAMI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39th Annual J.P. Morgan Healthcare Conference being held virtually o...
OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.
ELMWOOD PARK, N.J., Jan. 4, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools thr...
NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics...
OPKO Health has been experiencing an historic year in terms of business achievements, execution, and public recognition. The current Opko share price has been trading at extremely depressed levels recen...
These interesting low-cost stocks have the opportunity to grow.
MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D. as an independent member of its Board of Directors, effective December 18, 2...
Having college and professional athletes play sports during a pandemic can create logistics problems with social distancing and COVID-19 testing. Two small cap companies have won contracts to help leagu...
Rumors of a potential sale of the company's growth hormone royalty stream excited investors.
OPKO Health, Inc. (OPK) Management Presents at Jefferies 2020 Virtual London Healthcare Conference (Transcript)
About OPK
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers ... [Read more...]
| Industry Diagnostics & Research | IPO Date Nov 2, 1995 |
| CEO Phillip Frost | Employees 5,269 |
| Stock Exchange NASDAQ | Ticker Symbol OPK |
Analyst Forecasts
According to 5 analysts, the average rating for OPKO Health stock is "Buy." The 12-month stock price forecast is 8.25, which is an increase of 119.71% from the latest price.